Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE CANNES GRAND BLEU : revenue, balance sheet and financial ratios

PHARMACIE CANNES GRAND BLEU is a French company founded 5 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CANNES (06150), this company of category PME shows in 2024 a net income positive of 75 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE CANNES GRAND BLEU (SIREN 891498172)
Indicator 2024 2023 2022
Revenue N/C N/C N/C
Net income 75 440 € 83 548 € 164 779 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2024, PHARMACIE CANNES GRAND BLEU generates positive net income of 75 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2024: 165 k€ -> 75 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

75 440 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 49%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

48.731%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

60.385%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

36.9%

Solvency indicators evolution
PHARMACIE CANNES GRAND BLEU

Sector positioning

Debt ratio
48.73 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good -14 pts over 3 years

In 2024, the debt ratio of PHARMACIE CANNES GRAND BLEU (48.73) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
60.38% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +24 pts over 3 years

In 2024, the financial autonomy of PHARMACIE CANNES GRAND BLEU (60.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 510.44. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

510.443

Liquidity indicators evolution
PHARMACIE CANNES GRAND BLEU

Sector positioning

Liquidity ratio
510.44 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent

In 2024, the liquidity ratio of PHARMACIE CANNES GRAND BLEU (510.44) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of PHARMACIE CANNES GRAND BLEU in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE CANNES GRAND BLEU is estimated at 1 053 198 € (range 733 430€ - 1 575 644€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
733k€ 1053k€ 1575k€
1 053 198 € Range: 733 430€ - 1 575 644€
NAF 5 année 2024

Valuation method used

Net Income Multiple
75 440 € × 14.0x = 1 053 198 €
Range: 733 431€ - 1 575 645€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE CANNES GRAND BLEU with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE CANNES GRAND BLEU

What is the revenue of PHARMACIE CANNES GRAND BLEU ?

The revenue of PHARMACIE CANNES GRAND BLEU is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE CANNES GRAND BLEU profitable?

Yes, PHARMACIE CANNES GRAND BLEU generated a net profit of 75 k€ in 2024.

Where is the headquarters of PHARMACIE CANNES GRAND BLEU ?

The headquarters of PHARMACIE CANNES GRAND BLEU is located in CANNES (06150), in the department Alpes-Maritimes.

Where to find the tax return of PHARMACIE CANNES GRAND BLEU ?

The tax return of PHARMACIE CANNES GRAND BLEU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE CANNES GRAND BLEU operate?

PHARMACIE CANNES GRAND BLEU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.